When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network.
Whsmith.co.uk

Springer Nature Switzerland AG Atlas Of Response To Immunotherapy

Whsmith.co.uk

Springer Nature Switzerland AG Atlas Of Response To Immunotherapy

This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI).The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment.A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases.To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy.The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario.The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.

from £91.99
Seller: Whsmith.co.uk

Latest products

By Continuing to use this site you confirm, your consent to us and our partners collecting data from you, using cookies to serve personalised ads, tailoring content to you and optimising the site itself. You can learn more about the collection and use of your data and to change your preferences at any time by seeing our Privacy Policy and Cookie Policy.
Accept